Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

OBJECTIVE: Due to long lag time between infection/cancer diagnoses human papillomavirus (HPV) vaccination programs will deliver vaccine efficacy (VE) estimates against cancer end-points late. Cancer registry follow-up of population-based, randomised trial cohorts of vaccinated and unvaccinated women...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehtinen, Matti, Lagheden, Camilla, Luostarinen, Tapio, Eriksson, Tiina, Apter, Dan, Harjula, Katja, Kuortti, Marjo, Natunen, Kari, Palmroth, Johanna, Petäjä, Tiina, Pukkala, Eero, Siitari-Mattila, Mari, Struyf, Frank, Nieminen, Pekka, Paavonen, Jorma, Dubin, Gary, Dillner, Joakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629648/
https://www.ncbi.nlm.nih.gov/pubmed/28821519
http://dx.doi.org/10.1136/bmjopen-2017-015867

Ejemplares similares

Ejemplares similares